HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 2.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 210,313 shares of the company’s stock after purchasing an additional 4,784 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.08% of HCA Healthcare worth $56,927,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in HCA. Norges Bank purchased a new position in shares of HCA Healthcare during the 4th quarter worth about $694,985,000. Capital World Investors increased its holdings in shares of HCA Healthcare by 112.1% during the 4th quarter. Capital World Investors now owns 1,772,627 shares of the company’s stock worth $479,815,000 after buying an additional 936,823 shares during the last quarter. Sanders Capital LLC boosted its holdings in HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after acquiring an additional 456,738 shares during the last quarter. TD Asset Management Inc increased its stake in HCA Healthcare by 230.5% during the fourth quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock worth $149,747,000 after acquiring an additional 385,854 shares during the last quarter. Finally, Magellan Asset Management Ltd grew its holdings in shares of HCA Healthcare by 41.7% during the 4th quarter. Magellan Asset Management Ltd now owns 1,131,932 shares of the company’s stock worth $306,391,000 after purchasing an additional 333,254 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on HCA shares. JPMorgan Chase & Co. raised their target price on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a research note on Thursday, May 30th. Deutsche Bank Aktiengesellschaft upped their target price on HCA Healthcare from $330.00 to $359.00 and gave the stock a “buy” rating in a research report on Friday, April 12th. Robert W. Baird began coverage on HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price target on the stock. Royal Bank of Canada boosted their target price on shares of HCA Healthcare from $322.00 to $329.00 and gave the stock an “outperform” rating in a research report on Monday, April 29th. Finally, Barclays boosted their price objective on shares of HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a report on Monday, April 29th. Four investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $325.59.

Read Our Latest Stock Report on HCA Healthcare

Insider Buying and Selling at HCA Healthcare

In other news, SVP Chad J. Wasserman sold 876 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the transaction, the senior vice president now directly owns 1,576 shares in the company, valued at $520,474. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, SVP Kathryn A. Torres sold 1,863 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total transaction of $607,673.34. Following the transaction, the senior vice president now owns 19,612 shares in the company, valued at $6,397,042.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Chad J. Wasserman sold 876 shares of the stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total value of $289,299.00. Following the transaction, the senior vice president now directly owns 1,576 shares of the company’s stock, valued at $520,474. The disclosure for this sale can be found here. Insiders sold 13,617 shares of company stock valued at $4,321,986 in the last ninety days. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 1.1 %

HCA stock opened at $341.26 on Tuesday. The firm has a fifty day moving average price of $319.67 and a two-hundred day moving average price of $310.91. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $342.28. The firm has a market cap of $89.38 billion, a price-to-earnings ratio of 17.01, a PEG ratio of 1.56 and a beta of 1.69.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. The firm had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. HCA Healthcare’s revenue was up 11.2% on a year-over-year basis. During the same quarter last year, the company posted $4.93 earnings per share. Research analysts predict that HCA Healthcare, Inc. will post 20.92 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be given a dividend of $0.66 per share. The ex-dividend date is Friday, June 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.77%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.